Publications by authors named "David Trueman"

Claim this Profile
E
Estimated Long-Term Durability of Valoctocogene Roxaparvovec Treatment in Male patients with Severe Hemophilia A: An Extrapolation of Clinical Data.
Sandra Santos, Tara M Robinson, David Trueman

Adv Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Indirect Treatment Comparison of Lenvatinib for the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma.
Kerigo Ndirangu, Abby Paine, Hollie Pilkington, David Trueman

Adv Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab Vedotin Plus CHP in Frontline sALCL: Adjusted Estimates of Efficacy and Cost-Effectiveness Removing the Effects of Re-Treatment with Brentuximab Vedotin.
Holly Cranmer, David Trueman, Elise Evers, Fionn Woodcock, Tanja Podkonjak

Pharmacoecon Open· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Patients with Elevated Low-Density Lipoprotein Cholesterol Despite Statin Use: A Threshold Analysis.
Nihar R Desai, Caresse Campbell, Batul Electricwala, Margaret Petrou, David Trueman

Am J Cardiovasc Drugs· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of brigatinib in adult patients with ALK inhibitor-naive ALK-positive non-small cell lung cancer from a US perspective.
Holly Cranmer, Isabella Kearns, Melanie Young, Michael J Humphries, David Trueman

J Manag Care Spec Pharm· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost-Effectiveness of Lenvatinib in the Treatment of Advanced or Unresectable Hepatocellular Carcinoma from a Canadian Perspective.
Brandon M Meyers, Arndt Vogel, Paul Marotta, Petr Kavan, Laveena Kamboj, David Trueman

Can J Gastroenterol Hepatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical and cost-effectiveness of supplemental parenteral nutrition in oncology.
Neil Webb, Julie Fricke, Elizabeth Hancock, David Trueman, Srobana Ghosh

ESMO Open· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incomplete Spinal Cord Injury With Concurrent Hypertrophic Obstructive Cardiomyopathy.
Matthew Jensen, Robert Brown, David Trueman, Katherine Rodman, Harinder Dhindsa

Air Med J· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK.
Daniel Viriato, Natalie Bennett, Raisa Sidhu, Elizabeth Hancock, Hannah Lomax, David Trueman

Adv Ther· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RE: Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction.
Joaquim Cristino, Immanuel Tang, Caroline Ng, Jonathan Tan, David Trueman

J Med Econ· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction.
Zanfina Ademi, Alena M Pfeil, Elizabeth Hancock, David Trueman, Rola Haroun Haroun

Swiss Med Wkly· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction.
John J V McMurray, David Trueman, Elizabeth Hancock, Martin R Cowie, Andrew Briggs

Heart· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the Disease.
Robert Hodgson, Timothy Reason, David Trueman, Rose Wickstead, Jeanette Kusel

Adv Ther· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review.
Elena Olariu, Kevin K Cadwell, Elizabeth Hancock, David Trueman, Helene Chevrou-Severac

Clinicoecon Outcomes Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland.
Colette Mankowski, Sachin Patel, David Trueman, Anthony Bentley, Chris Poole

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia.
Krithika Rajagopalan, David Trueman, Lydia Crowe, Daniel Squirrell, Antony Loebel

Pharmacoeconomics· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
Clare Jamookeeah, Paul Robinson, Karl O'Reilly, Johan Lundberg, Martin Gisby, David Trueman

BMC Endocr Disord· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled aztreonam lysine versus inhaled tobramycin in cystic fibrosis. An economic evaluation.
Michael S Schechter, David Trueman, Rachel Farquharson, Keiko Higuchi, Cori L Daines

Ann Am Thorac Soc· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will the Supreme Court finally eliminate ERISA preemption?
David L Trueman

Ann Health Law· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case study: Boerhaave's syndrome.
David Trueman

Air Med J· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the recent Supreme Court rulings in Pegram and Rush Prudential on state regulation of managed care organizations.
David L Trueman

J Health Law· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The liability of medical directors for utilization review decisions.
David L Trueman

J Health Law· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis